Kwaliba inshila shalekanalekana isha kundapilamo kansa ya ku prostate, ukulingana no mushinku wa kansa na maka yaiko, e lyo no bumi bwa mulwele no fyo afwaya.
Inshila shimo isho abantu babomfya pa kundapa ubulwele bwa lupus ni ishi:
1. Ukuceceta bwino: Ukuceceta bwino kulalenga umuntu ukuceceta bwino kansa no kumupima lyonse, ukucila ukutendeka bwangu ukumundapa.
Kuti caba bwino ku baume abakwata kansa ya ku prostate iyabipa sana.
2. Ukulepula: Ukulepula kwa prostatectomy ni nshila ya kulepwilamo umulopa wa prostate gland.
Kuti bacitamo ukulepula ukwabulamo icilonda nelyo ukubomfya ifya kupiminako (ukubomfya ifya kupiminako ifinono ne fya kubomfya pa kupima).
3. Umuti wa radiation: Umuti wa radiation ulabomfya sana amaka ya muli bongobongo pa kwipaya insandesande sha kansa.
Kuti baipangila mu mubili (ukufuma ku mashini iyaba ku nse ya mubili) nelyo mu kati (ukufuma ku fya kubikamo ifyaba mupepi no busungu).
4. Ubulwele bwa kansa ya ku matako: Ubulwele bwa kansa ya ku matako bulalenga umulume ukukanaba sana na maka ya kucita ifyo umubili ufwaya.
Kuti yabomfiwa ku kansa ya prostate iyafika pa bukalamba iyo abasambilila imiti imbi bafilwa ukundapa.
7. Ubulwele bwa kansa ubulenga umuntu ukufwa: Ubulwele bwa kansa bulenga umuntu ukufwa ku nsandesande shimo ishilenga kansa ukulakula no kutwalilila.
Kuti yabomfiwa ku kansa ya prostate iyafika pa bukalamba iyo abasambilila imiti imbi bafilwa ukundapa.
8. Cryotherapy: Umuti wa kucefyako ubukali bwa kansa ubomfya umwela uwatalala sana pa kucefyako ubukali bwa kansa no kwipaya insandesande sha kansa.
Kuti yabomfiwa ku kansa ya ku prostate iyalatendeka nelyo iyabwelelako pa numa ya kundapwa.
9. High-intensity focused ultrasound (HIFU): Iyi miti ibomfya ifiunda fya kucincimuka sana pa kucincimusha no konaula insandesande sha kansa.
Kuti yabomfiwa ku kansa ya ku prostate iyalatendeka nelyo iyabwelelako pa numa ya kundapwa.
10. Ukucenjela: Iyi nshila ya kukonka ilanda pa kuceceta bwino bwino kansa ukupitila mu kupimwa lyonse, lelo te kuti batendeke ukundapa kano fye nga kwaba ifishibilo nelyo nga fyayaluka.
Kuti caba bwino ku bakalamba abakwata kansa ya ku prostate iilekula panono panono na ku balwele bambi abakwata amalwele ayakalamba.
Cikankaala ukulanshanya ne bumba lya badokota pa nshila sha kundapilamo no kwishiba inshila iisuma iya kundapilamo umuntu umo na umo.
Wang Y, Chen J, Wu Z, Ding W, Gao S, Gao Y, Xu C: Mechanisms of enzalutamide resistance in castration-resistant prostate cancer and therapeutic strategies to overcome it. Br J Pharmacol. 2021, 178 (2): 239-261.
Talkar SS, Patravale VB: Gene Therapy for Prostate Cancer: A Review. Endocr Metab Immune Disord Drug Targets. 2021, 21 (3): 385-396.
Šamija I, Fröbe A: CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER. Acta Clin Croat. 2019, 58 (Suppl 2): 76-81.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kagawa S, Kitamura T, Tsukamoto T, Naito S, Hirao Y, Murai M, Yamanaka H, Namiki M: The case for androgen deprivation as primary therapy for early stage disease: results from J-CaP and CaPSURE. J Urol. 2006, 176 (6 Pt 2): S47-9.
Abraham-Miranda J, Awasthi S, Yamoah K: Immunologic disparities in prostate cancer between American men of African and European descent. Crit Rev Oncol Hematol. 2021, 164 (): 103426.
de Vrij J, Willemsen RA, Lindholm L, Hoeben RC, Bangma CH, Barber C, Behr JP, Briggs S, Carlisle R, Cheng WS, Dautzenberg IJ, de Ridder C, Dzojic H, Erbacher P, Essand M, Fisher K, Frazier A, Georgopoulos LJ, Jennings I, Kochanek S, Koppers-Lalic D, Kraaij R, Kreppel F, Magnusson M, Maitland N, Neuberg P, Nugent R, Ogris M, Remy JS, Scaife M, Schenk-Braat E, Schooten E, Seymour L, Slade M, Szyjanowicz P, Totterman T, Uil TG, Ulbrich K, van der Weel L, van Weerden W, Wagner E, Zuber G: Adenovirus-derived vectors for prostate cancer gene therapy. Hum Gene Ther. 2010, 21 (7): 795-805.
Lee E, Ha S, Logan SK: Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One. 2015, 10 (10): e0141589.
['Ukufumyamo: kwa cipatala']
['Iyi webusaiti yabelako ku kusambilisha fye abantu kabili te ya kubomfya pa kundapa.']
['Ifyebo fyaba pali iyi webusaiti tafifwile ukubomfiwa ku kwishiba ubulwele umuntu akwete nelyo ukuundapa ubulwele, kabili abafwaya ukupanda amano pa fya kundapwa bafwile ukuipusha badokota.']
['Moneni ukuti neural net iileasuka ifipusho, ilingi line tailondolola bwino bwino ifyebo, pamo nga impendwa ya bantu abalwala ubulwele bumo.']
['Lyonse muleipusha badokota nelyo ababomfi ba cipatala pa fyo mwingacita pa bumi bwenu. Mwilaleka ukumfwa ifyo badokota balanda pa mulandu wa fyebo mwabelenga pali iyi webusaiti. Nga mwamona ukuti namulwala ubulwele ubukalamba, mufwile ukwita bwangu ku cipatala. Iyi webusaiti nelyo ifyo mubomfya iyi webusaiti tafilenga mwaumfwana na badokota nelyo abalwele. BioMedLib na babomfi baiko, nelyo abaibikamo, tabapeelako uuli onse umulandu, nangu fye ni mu kulungatika nelyo mu kukanailanda, pa fyebo fyaba pali iyi webusaiti nelyo ifyo babomfya.']
['Ukufumyamo: insambu sha kulemba']
['Ifunde lya Digital Millennium Copyright Act ilya mu 1998, 17 U.S.C. § 512 (the DMCA) lyapeela inshila sha kupwishishamo ubwafya ku bene ba fipe abaishiba ukuti ifyebo fyaba pa Intaneti filatoba insambu shabo ukulingana ne funde lya U.S. pa fya mafunde ya kuicingilila. ']
['Nga mwamona ukuti ifyebo fimo nelyo ifintu fimbi ifyo babika pa webusaiti yesu nelyo pa milimo yesu fyalipula mu nsambu sha bene, imwe (nangu umwiminishi wenu) kuti mwatutumina kalata ya kutweba ukuti tufumye ifyo fyebo nelyo ifyo fintu, nelyo ukuti tuleke ukufibomfya. ']
['Ukutumina abantu amameseji pa Intaneti (moneni akabokoshi akaleti "Kutuminako Bamunyinefwe" pa kuti mwishibe ama adresi ya pa Intaneti) ].']
['Ifunde lya DMCA litila mu mashiwi ya musango wa kuti umuntu nacita ifyo mulefwaya, mufwile ukulembapo ifyebo pamo nga: (1) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (2) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (3) ifyo mwingatutumina ifyebo, pamo nga adresi yenu, inambala ya foni, e lyo na adresi ya e-mail; (4) ifyo mwingalanda ukuti mulesumina ukuti ifyo mulefwaya ukupeela abantu te fyo umwine wa ici citabo, nelyo umwiminishi wakwe, nelyo ifunde limbi lyalanda. ']
['(5) amashiwi yenu ayalembwa, aya kuti nga mwafilwa ukulemba, mukapeelwa umulandu wa bufi, ukuti ifyebo fyaba muli aya mashiwi fya cine kabili mwalikwata amaka ya kucingilila insambu sha bene isho mulefwaya ukufyenga; ']
['Kabili (6) ukusuminisha kwa mwine wa fipe nelyo ukwa muntu uwapeelwa insambu sha kucita ifintu pa mulandu wakwe. ']
['Mukwai tumeni kalata ya ku email pa kwipusha icili conse nelyo ukutupeela amano.']
How to treat prostate cancer?
There are several treatment options available for prostate cancer, depending on the stage and aggressiveness of the cancer, as well as the patient's overall health and personal preferences.
Some common treatments include:
1. Active surveillance: This approach involves closely monitoring the cancer with regular checkups and tests, rather than immediately starting treatment.
It may be suitable for men with low-risk prostate cancer.
2. Surgery: A prostatectomy is a surgical procedure to remove the prostate gland.
It can be done through open surgery or laparoscopically (using small incisions and specialized tools).
3. Radiation therapy: This treatment uses high-energy radiation to kill cancer cells.
It can be delivered externally (from a machine outside the body) or internally (through implants placed near the tumor).
4. Hormone therapy: This treatment reduces the levels of male hormones (androgens) in the body, which can slow or stop the growth of prostate cancer.
It can be used alone or in combination with other treatments.
5. Chemotherapy: This treatment uses drugs to kill cancer cells.
It may be used for advanced prostate cancer that has spread to other parts of the body.
6. Immunotherapy: This treatment helps the immune system fight cancer.
It may be used for advanced prostate cancer that has not responded to other treatments.
7. Targeted therapy: This treatment targets specific genes or proteins that help cancer cells grow and survive.
It may be used for advanced prostate cancer that has not responded to other treatments.
8. Cryotherapy: This treatment uses extreme cold to freeze and kill cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
9. High-intensity focused ultrasound (HIFU): This treatment uses high-frequency sound waves to heat and destroy cancer cells.
It may be used for early-stage prostate cancer or for cancer that has come back after other treatments.
10. Watchful waiting: This approach involves closely monitoring the cancer with regular checkups and tests, but not starting treatment unless symptoms appear or change.
It may be suitable for older men with slow-growing prostate cancer and other serious health conditions.
It is important to discuss all treatment options with a healthcare team to determine the best course of action for each individual case.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Pa lwa']
['BioMedLib ibomfya amakompyuta ayabomba (amakompyuta ayaishiba ukulemba) pa kupanga ifipusho ne fyasuko.']
['Twatendekelepo ne mpapulo sha mu fipatala 35 milioni isha mu PubMed/Medline.']
